Envoy Medical (COCH) to Release Quarterly Earnings on Monday

Envoy Medical (NASDAQ:COCH) is expected to be issuing its quarterly earnings data before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.33) per share for the quarter.

Envoy Medical (NASDAQ:COCH) last posted its quarterly earnings data on Friday, March 28th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.12). The business had revenue of $0.04 million during the quarter, compared to analysts’ expectations of $0.07 million. On average, analysts expect Envoy Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Envoy Medical Trading Down 0.4 %

Shares of COCH stock opened at $1.38 on Friday. The business’s 50 day moving average is $1.45 and its two-hundred day moving average is $1.96. Envoy Medical has a twelve month low of $1.21 and a twelve month high of $7.20. The company has a market capitalization of $27.84 million, a P/E ratio of -0.98 and a beta of 2.35.

Analyst Upgrades and Downgrades

Separately, Ascendiant Capital Markets upped their price objective on shares of Envoy Medical from $8.75 to $9.00 and gave the stock a “buy” rating in a research report on Friday, December 6th.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.